Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes

por Rébé, Cédric, Filomenko, Rodolphe, Raveneau, Magalie, Chevriaux, Angélique, Ishibashi, Minako, Lagrost, Laurent, Junien, Jean Louis, Gambert, Philippe, Masson, David
Publicado 2012

Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis

por Ruzehaji, Nadira, Frantz, Camelia, Ponsoye, Matthieu, Avouac, Jerome, Pezet, Sonia, Guilbert, Thomas, Luccarini, Jean-Michel, Broqua, Pierre, Junien, Jean-Louis, Allanore, Yannick
Publicado 2016

Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models

por Entchev, Eugeni, Jantzen, Ingrid, Masson, Philippe, Bocart, Stephanie, Bournique, Bruno, Luccarini, Jean-Michel, Bouchot, Andre, Lacombe, Olivier, Junien, Jean-Louis, Broqua, Pierre, Tallandier, Mireille
Publicado 2020

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis

por Derrett-Smith, Emma, Clark, Kristina E. N., Shiwen, Xu, Abraham, David J., Hoyles, Rachel K., Lacombe, Olivier, Broqua, Pierre, Junien, Jean Louis, Konstantinova, Irena, Ong, Voon H., Denton, Christopher P.
Publicado 2021

The new‐generation pan‐peroxisome proliferator‐activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis

por Wettstein, Guillaume, Luccarini, Jean‐Michel, Poekes, Laurence, Faye, Patrick, Kupkowski, Francine, Adarbes, Vanessa, Defrêne, Evelyne, Estivalet, Céline, Gawronski, Xavier, Jantzen, Ingrid, Philippot, Alain, Tessier, Julien, Tuyaa‐Boustugue, Pascale, Oakley, Fiona, Mann, Derek A., Leclercq, Isabelle, Francque, Sven, Konstantinova, Irena, Broqua, Pierre, Junien, Jean‐Louis
Publicado 2017